Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/50265
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2020-01-09T13:02:56Z | - |
dc.date.available | 2020-01-09T13:02:56Z | - |
dc.date.issued | 2014-03 | - |
dc.identifier.citation | Grech, L., Coleiro, B., Borg, A. A., Serracino-Inglott, A., & Azzopardi, L. M. (2014, March). Identification of pharmaceutical care needs for rheumatoid arthritis patients on methotrexate. Poster session presented at the Pharmaceutical Care Network Europe (PCNE) Conference, Sliema, Malta. | en_GB |
dc.identifier.uri | https://www.um.edu.mt/library/oar/handle/123456789/50265 | - |
dc.description.abstract | A poster presentation regarding the identification of pharmaceutical care needs for rheumatoid arthritis patients on methotrexate. Introduction: Effective and safe management of rheumatoid arthritis patients depends on safe prescribing, monitoring and administration of disease modifying antirheumatic drugs, biological agents and biosimilars. A pharmaceutical care framework implemented within a multidisciplinary care clinic can further substantiate and improve pharmacological management of rheumatoid arthritis patients resulting in improved service provision to the patients. Aims: To assess the impact of a pharmaceutical care service offered to rheumatoid arthritis patients within the Rheumatology Out-Patient setting in a general public hospital. | en_GB |
dc.language.iso | en | en_GB |
dc.publisher | University of Malta. Department of Pharmacy | en_GB |
dc.rights | info:eu-repo/semantics/openAccess | en_GB |
dc.subject | Rheumatoid arthritis -- Patients -- Care | en_GB |
dc.subject | Rheumatoid arthritis -- Chemotherapy -- Malta -- Case studies | en_GB |
dc.subject | Methotrexate | en_GB |
dc.subject | Drugs -- Prescribing -- Safety measures | en_GB |
dc.subject | Pharmacist and patient | en_GB |
dc.subject | Patient monitoring | en_GB |
dc.title | Identification of pharmaceutical care needs for rheumatoid arthritis patients on methotrexate | en_GB |
dc.type | presentation | en_GB |
dc.rights.holder | The copyright of this work belongs to the author(s)/publisher. The rights of this work are as defined by the appropriate Copyright Legislation or as modified by any successive legislation. Users may access this work and can make use of the information contained in accordance with the Copyright Legislation provided that the author must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the prior permission of the copyright holder. | en_GB |
dc.description.reviewed | N/A | en_GB |
dc.contributor.creator | Grech, Louise | - |
dc.contributor.creator | Coleiro, Bernard | - |
dc.contributor.creator | Borg, Andrew A. | - |
dc.contributor.creator | Serracino-Inglott, Anthony | - |
dc.contributor.creator | Azzopardi, Lilian M. | - |
Appears in Collections: | Scholarly Works - FacM&SPha |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Identification_of_pharmaceutical_care_needs_for_rheumatoid_arthritis_patients_on_methotrexate_2014.pdf | 425.43 kB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.